• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylmethanes

Recent Advances in the Study of Benzhydryl Isothiocyanate (CAS: 3550-21-8): A Comprehensive Research Brief

Benzhydryl isothiocyanate (CAS: 3550-21-8) has emerged as a compound of significant interest in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. Recent studies have focused on elucidating its mechanism of action, optimizing its synthesis, and exploring its biological activities. This research brief aims to provide a comprehensive overview of the latest findings related to this compound, highlighting its potential in drug development and other biomedical applications.

One of the key areas of research has been the synthesis and structural modification of Benzhydryl isothiocyanate. A study published in the Journal of Medicinal Chemistry (2023) reported an improved synthetic route for this compound, achieving higher yields and purity. The researchers utilized a novel catalytic system that enhanced the efficiency of the reaction, making it more suitable for large-scale production. This advancement is particularly important for future preclinical and clinical studies, where a reliable and scalable synthesis method is crucial.

In addition to synthetic improvements, recent investigations have explored the biological activities of Benzhydryl isothiocyanate. A 2023 study in Bioorganic & Medicinal Chemistry Letters demonstrated its potent inhibitory effects on certain cancer cell lines, particularly those associated with breast and prostate cancers. The compound was found to induce apoptosis through the activation of specific signaling pathways, suggesting its potential as a chemotherapeutic agent. Further in vivo studies are underway to validate these findings and assess the compound's safety profile.

Another promising area of research involves the use of Benzhydryl isothiocyanate as a scaffold for the development of new antimicrobial agents. A recent publication in Antimicrobial Agents and Chemotherapy (2023) highlighted its efficacy against multidrug-resistant bacterial strains, including methicillin-resistant Staphylococcus aureus (MRSA). The study revealed that the compound disrupts bacterial cell membrane integrity, leading to cell death. These findings open new avenues for addressing the global challenge of antibiotic resistance.

Despite these advancements, challenges remain in the development of Benzhydryl isothiocyanate-based therapeutics. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further research. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to overcome these hurdles and translate the compound's potential into clinical applications.

In conclusion, Benzhydryl isothiocyanate (CAS: 3550-21-8) represents a promising candidate for various biomedical applications, from cancer therapy to antimicrobial treatment. The latest research underscores its potential while also highlighting the need for continued investigation. As the field progresses, this compound may play a pivotal role in addressing some of the most pressing challenges in modern medicine.

• 1726-94-9(Trityl Isothiocyanate)
• 745784-02-5((S)-(+)-1-(4-Bromophenyl)ethyl isothiocyanate)
• 131074-55-0((S)-1-(1-Naphthyl)ethyl isothiocyanate)
• 24277-43-8(L-α-Methylbenzyl Isothiocyanate)
• 4478-92-6(1-phenylethyl isothiocyanate)
• 138617-82-0((R)-1-(1-Naphthyl)ethyl isothiocyanate)
• 28242-40-2(Benzene,1,1'-(isothiocyanatomethylene)bis[4-bromo-)
• 24277-44-9((-)-α-Methylbenzyl Isothiocyanate)
• 745784-01-4((R)-(+)-1-(4-Bromophenyl)ethyl isothiocyanate)
• 2257-09-2(Phenethyl Isothiocyanate)